Statistics for Adjuvant autologous melanoma vaccine for macroscopic stage III disease: survival, biomarkers, and improved response to CTLA-4 blockade
Total visits
| views | |
|---|---|
| Adjuvant autologous melanoma vaccine for macroscopic stage III disease: survival, biomarkers, and improved response to CTLA-4 blockade | 1 |
Total visits per month
| views | |
|---|---|
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
File Visits
| views | |
|---|---|
| Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease Survival, Biomarkers, and Improved Response to CTLA-4 Blockade.pdf | 16 |
Top country views
| views | |
|---|---|
| Turkey | 1 |
Top city views
| views | |
|---|---|
| Ankara | 1 |